Influence
June 20, 2025

Rectal location and postcolonoscopy colorectal cancer outcomes

Thomas Imperiale

Published in the JAMA Network Open. Here is a link to the article.

Regenstrief Institute authors: Thomas Imperiale, M.D.

This study examines the relationship between the anatomical location of postcolonoscopy colorectal cancers (PCCRCs) and patient mortality outcomes within the Veterans Health Administration (VHA) system. PCCRCs are cancers identified 6 to 36 months after a colonoscopy that failed to detect malignancy, and they are a key quality indicator of colonoscopy performance. While PCCRCs are commonly associated with the proximal colon, recent evidence highlights a notable incidence in the rectum—a region with distinct biological behavior and a tendency for local invasion.

Using VHA-Medicare data from 2003 to 2013, researchers identified 5,248 cases of rectal cancer and compared all-cause mortality (ACM) and cancer-specific mortality (CSM) between rectal PCCRCs and cancers detected within six months of colonoscopy (DCRC). Advanced statistical analyses, including Cox proportional hazards models, revealed no significant differences in ACM or CSM between rectal PCCRCs and rectal DCRCs. Similar comparisons between rectal and right colon PCCRCs yielded no statistically meaningful differences. A modest but statistically significant mortality difference was found when comparing rectal DCRCs to right colon DCRCs.

The findings suggest that rectal location and the PCCRC classification do not substantially impact mortality outcomes. However, limitations such as missing data on patient health factors and potential underreporting of non-VHA colonoscopies warrant cautious interpretation. This study reinforces the need for thorough inspection of the rectum during colonoscopy, as it remains a common site for missed cancers. Further investigation is recommended to understand contributing factors and improve detection strategies.

Authors: 

Charles J. Kahi, MD, MSc1,2,3Laura J. Myers, PhD2,3,5Patrick O. Monahan, PhD4Barry C. Barker, MA3Timothy E. Stump, MA3,4Thomas F. Imperiale, MD1,2,3,5

Affiliations: 

1Department of Medicine, Richard L. Roudebush VA Medical Center, Indianapolis, Indiana
2Health Services Research & Development, Richard L. Roudebush VA Medical Center, Indianapolis, Indiana
3Indiana University School of Medicine, Indianapolis
4Department of Biostatistics and Health Data Science, Indiana University School of Medicine, Indianapolis
5The Regenstrief Institute, Indianapolis, Indiana

Partners

Related News

Dr. Babar Khan on All IN

Renowned delirium researcher and clinician named Regenstrief interim center director

Babar Khan, M.D., M.S., a renowned delirium research scientist and pulmonary and critical care clinician, has been named interim

Regenstrief Research Scientist Wanzhu Tu, PhD

Parental liver disease death more than doubles risk of alcohol-associated hepatitis in next generation

In a groundbreaking study, research scientists from the Indiana University School of Medicine and Regenstrief Institute found that individuals

image of elderly woman discussing pill bottle with her doctor

American Geriatrics Society unveils updated alternatives to potentially harmful medications for older adults

Regenstrief researcher serves on expert panel providing clinicians, patients and families with credible, actionable alternatives The American Geriatrics Society

LOINC version 2.81 release

Arabic and Czech translations, more than 4,000 new concepts boost global interoperability in latest LOINC® release

Regenstrief Institute’s latest LOINC® content update on August 12, introduces two new linguistic variants: Arabic, for users in Jordan,